cbdMD Inc

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded by Caryn Dunayer on March 17, 2015 and is headquartered in Charlotte, NC.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the nation's leading and most highly trusted and recognized cannabidiol (CBD) brands, today announced its financial results and its business highlights for its third quarter and nine months ended June 30, 2021. Financial highlights for the Quarter Ended June 30, 2021: Net sales of $10.6 million for the third quarter of fiscal 2021 remained steady year-over-year resulting in record trailing twelve-month net sales

cbdMD Reports Third Quarter Fiscal 2021 Results

IM Cannabis Corp

Cannabidiol brand cbdMD, Inc. (NYSE:YCBD) has teamed up with IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) to enter the Israeli market. Based in Charlotte, North Carolina, cbdMD reported Monday it has inked a binding letter of intent with the multi-country company operating in Israel, Germany and Canada.

cbdMD Stock Trading Down After Announcing Deal With IM Cannabis Corp. To Enter Israel

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today the signing of a binding letter of intent with IM Cannabis Corp. (CSE: IMCC, NASDAQ: IMCC) (“IMC”), a multi-country operator (“MCO”) in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada. Terms of the agreement will grant IMC an exclusive right to import, sell, distribute and marke

cbdMD Signs Exclusive Agreement to Enter Israeli Market with IM Cannabis Corp.

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading and most highly trusted and recognized CBD health & wellness companies, announced today that it will host a conference call at 4:15 p.m., Eastern Time, on Thursday, August 12, 2021, to discuss the company's June 30, 2021 third quarter financial results and business progress. CONFERENCE CALL DETAILS Thursday, August 12, 2021, 4:15 p.m. Eastern Time   Domestic: 1-888-506-0062   International: 1-973

cbdMD, Inc. To Host Conference Call To Discuss June 30, 2021 Third Quarter Results

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that it has entered into a letter of intent to purchase leading CBD online marketplace, DirectCBDOnline.com, from Twenty Two Capital, LLC. “Owning a CBD online marketplace that sells various CBD brands provides unique transparency to better understand consumer spending habits and trends across the wider CBD and hemp marketplace. I

cbdMD Enters into Letter of Intent To Purchase DirectCBDOnline.com

Flora Growth Corp

HEXO Corp

Innovative Industrial Properties

Amplify Alternative Harvest ETF

ETFMG 2X Daily Alternative Harvest ETF

SNDL Inc.

Tilray Brands

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

Cannabis Industry Movers and Shakers This Week

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use. The Company also anticipates the identification of dietary supplement applications through this process. The Company expects to finalize the agre

cbdMD Therapeutics Releases Research Plan

GrowGeneration Corp

Coffee Holding

Village Farms International

22nd Century Group

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry continues to shape up in 2021.

Pot Stock Roundup: Apple Enters the Fray

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), today announced the closing of its previously announced underwritten public offering for total gross proceeds of $16,500,000, before deducting underwriting discounts, commissions, and other offering expenses payable by the company. cbdMD, Inc. sold an aggregate of 2,200,000 shares of its 8.0% Series A Cumulative Convertible Preferred Stock, which includes 286,900 shares sold upon full exercise of the over-allotment opt

cbdMD, Inc. Announces Closing of Underwritten Public Offering of 8.0% Series A Cumulative Convertible Preferred Stock and Full Exercise of Underwriter's Over-allotment Option for Total Gross Proceeds of $16.5 Million

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA) today announced the pricing of its underwritten public offering of 1,913,100 shares of its 8.0% Series A Cumulative Convertible Preferred Stock at a price to the public of $7.50 per share. cbdMD expects to receive gross proceeds of $14,348,250 from the offering. The closing of the offering is expected to occur on or about July 1, 2021, subject to the satisfaction of customary closing conditions. The shares will be conve

cbdMD, Inc. Announces Pricing of $14.3 Million 8.0% Series A Cumulative Convertible Preferred Stock Offering

MedMen Enterprises Inc.

Cantor Fitzgerald's Pablo Zuanic provided updated ratings and estimates on several stocks from the cannabis and CBD sector, those being – MedMen Enterprises (OTCQF: MMNFF), Jushi Holdings (OTCQB: JUSHF), cbdMD (AMEX: YCBD), and CV Sciences (OTCQB: CVSI). The Analyst's View On Thursday, Zuanic kept an ‘Underweight' rating on MedMen stock, while in an earlier note, he withdrew their price target.

Cantor Updates Ratings On Several Cannabis And CBD Stocks - MedMen, Jushi, cbdMD, CV Sciences

Cronos Group

Neptune Wellness Solutions Inc.

According to a recent report from ResearchAndMarkets.com, the global CBD market is expected to expand to $13.4 billion by 2028, reflecting a CAGR of over 21% from 2021 to 2028, making it one of the most explosive fast-growing markets in the developed-world economy. “Increasing awareness about the health benefits of cannabidiol (CBD), changing consumer opinion, […]

The Future of CBD is All About Distribution Positioning Like Real Brands Inc.

Aurora Cannabis

Applied DNA Sciences

Arena Pharmaceuticals

Canopy Growth

FSD Pharma

OrganiGram Holdings Inc.

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues to take shape in 2021.

Breaking Down a Busy Week of Weed Stocks

Will These Cannabis Stock Continue Moving Up In June? The post Top Marijuana Stocks To Buy Right Now? 2 To Watch This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Marijuana Stocks To Buy Right Now? 2 To Watch This Week

Turning Point Brands

The CBD stock bear market ended, officially, last year. But the recovery has been gradual and slow in gaining traction thus far.

A Roadmap for the Revival of CBD Stocks: Spotlight on YCBD, RLBD, and NEPT

Cara Therapeutics

Corbus Pharmaceuticals Holdings

Akerna Corp

Zynerba Pharmaceuticals

Here Are the Cannabis Stocks That Caught Fire This Week

cbdMD, Inc. (YCBD) CEO Martin Sumichrast on Q2 2021 Results - Earnings Call Transcript

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the nation's leading and most highly trusted and recognized cannabidiol (CBD) brands, today announced its financial results and its business highlights for its second quarter and six months ended March 31, 2021. Financial highlights for the Quarter Ended March 31, 2021: Net sales of $11.8 million for the second quarter of fiscal 2021 increased by 26% year-over-year from $9.4 million in the second quarter of fisc

cbdMD Reports Second Quarter Fiscal 2021 Results

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the nation's leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it has received the prestigious U.S. Hemp Authority™ Certification (USHA). The certification signifies the Company's efforts to provide a high-quality, trustworthy product and grants the right to use the Certified Seal of the U.S. Hemp Authority on all hemp product packaging and marketing materials. In addi

cbdMD Receives Prestigious U.S. Hemp Authority™ Certification

GW Pharmaceuticals

Jazz Pharmaceuticals

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in 2021.

What Happened with Marijuana Stocks This Week?

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one of the leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it has signed an exclusive sponsorship agreement to be the Official CBD Partner of the NOBULL CrossFit Games, which will be held in Madison, Wisconsin from July 27 to August 1. cbdMD will also be an Official Sponsor of the NOBULL CrossFit Games Semifinals, which will take place from May 28 to June 20

cbdMD Becomes Official CBD Partner of the NOBULL CrossFit Games

Greenlane Holdings

Curaleaf Holdings, Inc.

Delic Holdings Appoints Dr. Eric Janusson As Lead Chemist Complex Biotech Discovery Ventures Ltd., a licensed cannabis and psilocybin research laboratory, has appointed Dr. Eric Janusson as its lead chemist.

Cannabis Movers & Shakers: Fire & Flower, Acreage, cbdMD, Greenlane & KushCo, Digital Venture

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the world's leading, and most highly trusted and recognized health & wellness CBD companies, announced today that it will host a conference call at 4:15 p.m., Eastern Time, on Wednesday, May 12th, 2021, to discuss the company's March 31, 2021 second quarter financial results and business progress. CONFERENCE CALL DETAILS   Wednesday, May 12th, 2021, 4:15 p.m. Eastern Time   Domestic: 1-888-506-0062   Interna

cbdMD, Inc. to Host Conference Call to Discuss March 31, 2021, Second Quarter Results

Aphria

Philip Morris

Pyxus International Inc

These 10 Pot Stocks Smoked the Last Week of April

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it has hired Dr. Sibyl Swift, as Vice President for Scientific & Regulatory Affairs. The Company previously announced in February 2020 that Dr. Swift had been engaged as a regulatory consultant to oversee the Company's regulatory initiatives. She was also recently named as co-Chair of cbdMD Ther

cbdMD Announces Hiring of Dr. Sibyl Swift as VP of Scientific & Regulatory Affairs

News for cbdMD Inc Stock (YCBD)